Could a breath of CO2 save Stroke-Damaged brain tissue?
NCT ID NCT05051397
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether raising carbon dioxide levels slightly during general anesthesia can improve blood flow to the brain before clot removal in stroke patients. Fifty adults with large-vessel stroke will be randomly assigned to either normal or moderately high carbon dioxide levels during the procedure. The goal is to see if this simple gas adjustment helps keep brain tissue alive until the clot is removed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
carbon dioxide
What this could lead to
If it works, this could point toward a simple way to protect the brain during stroke treatment by using carbon dioxide to boost blood flow.
What could go wrong
This is a small, early-phase trial with only 50 participants. The approach may not improve outcomes or could cause harm if carbon dioxide levels are not carefully managed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBECTOMY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU
RECRUITINGClermont-Ferrand, 63000, France
Contact
Contact
Contact Email: •••••@•••••
Contact